Understanding the costs of Asthma: The next step

Kevin B. Weiss*, Sean D. Sullivan

*Corresponding author for this work

Research output: Contribution to journalReview article

11 Scopus citations

Abstract

The authors comment on Dr Murray Krahn and associates findings on the direct and indirect costs of asthma in Canada in 1990 (see pages 821 to 831 of this issue). They believe this study is the most meticulous of recent cost-of-illness analyses of the economic burden of asthma. They argue that although Krahn and associates study is a useful addition to the economic interature on this common disorder, the cost-of-illness method of analysis cannot address the question of the relative costs and benefits of specific interventions. The next task in improving the management of asthma is therefore to undertake studies that will allow clinical and administrative decision-makers to assess the relative cost-effectiveness of a range of available treatments.

Original languageEnglish (US)
Pages (from-to)841-843
Number of pages3
JournalCMAJ
Volume154
Issue number6
StatePublished - Dec 1 1996

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Understanding the costs of Asthma: The next step'. Together they form a unique fingerprint.

  • Cite this

    Weiss, K. B., & Sullivan, S. D. (1996). Understanding the costs of Asthma: The next step. CMAJ, 154(6), 841-843.